NasdaqCM - Delayed Quote USD
Athira Pharma, Inc. (ATHA)
0.2543
-0.0123
(-4.61%)
At close: May 9 at 4:00:01 PM EDT
0.2670
+0.01
+(4.99%)
After hours: May 9 at 7:30:52 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 3 | 2 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.74 | -0.71 | -0.41 | -0.24 |
| EPS Actual | -0.7 | -0.75 | -0.39 | -0.23 |
| Difference | 0.04 | -0.04 | 0.02 | 0.01 |
| Surprise % | 4.98% | -5.93% | 3.70% | 4.17% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ATHA | -- | -- | -- | -- |
| S&P 500 | 13.06% | 3.09% | 8.02% | 13.74% |
Upgrades & Downgrades
| Downgrade | Mizuho: Outperform to Neutral | 9/19/2024 |
| Downgrade | JMP Securities: Market Outperform to Market Perform | 9/4/2024 |
| Downgrade | BTIG: Buy to Neutral | 9/4/2024 |
| Initiated | Rodman & Renshaw: Buy | 8/19/2024 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 6/20/2024 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 5/16/2024 |
Related Tickers
ANTX AN2 Therapeutics, Inc.
1.2000
-1.64%
PMVP PMV Pharmaceuticals, Inc.
0.8827
-0.12%
HLVX HilleVax, Inc.
1.9000
-0.52%
TSBX Turnstone Biologics Corp.
0.3399
+2.13%
SPRB Spruce Biosciences, Inc.
0.0715
+2.14%
DSGN Design Therapeutics, Inc.
3.5000
-0.57%
OVID Ovid Therapeutics Inc.
0.2901
-1.33%
BOLT Bolt Biotherapeutics, Inc.
0.3580
-3.24%
LPTX Leap Therapeutics, Inc.
0.3350
-7.23%
ATXI Avenue Therapeutics, Inc.
0.2400
+9.04%